Mechanism of Action
DIFICID is bactericidal therapy that targets Clostridioides difficile
DIFICID has been shown to be active against most isolates of C. difficile, both in vitro and in clinical infections.
- Macrolide antibiotic bactericidal against C. difficile in vitro, inhibiting RNA synthesis by binding to RNA polymerases
- Acts locally in the gastrointestinal tract